September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
July 9th 2024
A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.
June 28th 2024
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
FDA Approves Second COVID-19 Vaccine, Moderna's Spikevax
Acting FDA Commissioner Janet Woodcock, MD, hopes the approval will help motivate more Americans to get vaccinated.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 31, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Shingles Vaccination Significantly Reduced Dementia Risk in Large Retrospective Cohort Study
In persons who received both the HZV and Tdap vaccines, a significant 50% reduction in risk of dementia was seen, suggesting a nonspecific underlying association.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 26, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 24, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 19, 2022
“Nocebo” Effect Accounted for Nearly Two-thirds of COVID-19 Vaccine Adverse Events in New Analysis
Findings highlight the importance of educating the public about the potential for nocebo responses to help reduce worries about COVID-19 vaccination.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 11, 2022
Non-COVID-19 Vaccines Could Help Reduce the Burden of Pandemic, Suggests New Research
New research suggests heterologous vaccine interventions with low efficacy can significantly reduce COVID-19 cases, hospitalizations, and deaths.
Shingles Vaccine Recap: A Shingrix Primer for Primary Care
Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 20, 2021
The CDC Recommends Pfizer, Moderna COVID Vaccines over J&J
The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Flu Called out by COVID as "Irrelevant," Flu Calls Press Conference, Issues Statement
COVID-19, in an attempt to bully Flu and potentially gain precious lung space in humans this year, provoked the veteran virus, labeling him as "irrelevant." Flu responds.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
FDA Extends Pfizer-BioNTech COVID-19 Vaccine Booster EUA to Cover 16-17-year-olds
Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.